The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
AG Blanche unveils federal charges against 160 defendants in pandemic relief sweep
Seven noncitizens charged in North Texas election-integrity investigation
Pentagon reveals secret space weapons are already in orbit — but won’t say what they do
WATCH: ‘Lifelong Democrat’ admits she is ‘ashamed’ of party after son killed in illegal immigrant crash
Karl Rove to Vote for Pro-Trans Dem After GOP Candidate Shares Texas Student Section Pic
Watch: Chiefs Used a Clever Bit of ‘Gamesmanship’ During TV Timeouts to Gain an Edge Over the Broncos
Minnesota attorney general says Somali Muslims have been defrauded by housing scheme claiming to be sharia-compliant
EXCLUSIVE: Inside Vance’s intimate Capitol Hill huddle as Republicans confront tough midterm terrain
Judge bars Kennedy Center board from putting Trump’s name on building at all
Facebook co-founder Dustin Moskovitz’s ‘effective altruism’ network tied to AI regulation push
Pentagon Inspector General Says Iran War Has Caused ‘Strategic Inventory Shortfalls’ of U.S. Munitions
Former CNN Host Reveals Father Beat Her Until She Was ‘Black and Blue’
Lindsay Clancy judge indefinitely impounds juror names, citing safety and ‘divisive’ attention
Army veteran paratrooper who deployed to Iraq, Afghanistan before helping rescue Fox News reporter dead at 50
China expert warns Beijing wants Americans — not the CCP — to spread its message
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
AG Blanche unveils federal charges against 160 defendants in pandemic relief sweep
Seven noncitizens charged in North Texas election-integrity investigation
Pentagon reveals secret space weapons are already in orbit — but won’t say what they do
WATCH: ‘Lifelong Democrat’ admits she is ‘ashamed’ of party after son killed in illegal immigrant crash
Karl Rove to Vote for Pro-Trans Dem After GOP Candidate Shares Texas Student Section Pic
Watch: Chiefs Used a Clever Bit of ‘Gamesmanship’ During TV Timeouts to Gain an Edge Over the Broncos
Minnesota attorney general says Somali Muslims have been defrauded by housing scheme claiming to be sharia-compliant
EXCLUSIVE: Inside Vance’s intimate Capitol Hill huddle as Republicans confront tough midterm terrain
Judge bars Kennedy Center board from putting Trump’s name on building at all
Facebook co-founder Dustin Moskovitz’s ‘effective altruism’ network tied to AI regulation push
Pentagon Inspector General Says Iran War Has Caused ‘Strategic Inventory Shortfalls’ of U.S. Munitions
Former CNN Host Reveals Father Beat Her Until She Was ‘Black and Blue’
Lindsay Clancy judge indefinitely impounds juror names, citing safety and ‘divisive’ attention
Army veteran paratrooper who deployed to Iraq, Afghanistan before helping rescue Fox News reporter dead at 50
China expert warns Beijing wants Americans — not the CCP — to spread its message
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
